Skip to main content
. 2024 Feb 6;24(2):100446. doi: 10.1016/j.ijchp.2024.100446

Table 7.

Aggregated benchmarks – treatment efficacy benchmarks for adolescents (full-programme).

Measure K N d+ σ2 CV Q p (Q)
BSL-23 3 151 0.800 0.009 0.48 1.705 .426

Note. K = number of studies; N = sample size; d+ = unbiased pre–post effect size estimate; σ2 = effect size variance; CV = Critical Value; Q = test of homogeneity; p = significance; BSL-23 = Borderline Symptom List;.